These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

309 related items for PubMed ID: 12731493

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Time for new rules on human subjects research?
    Dresser R.
    Hastings Cent Rep; 1998; 28(6):23-4. PubMed ID: 9868606
    [No Abstract] [Full Text] [Related]

  • 4. Protecting research subjects--what must be done.
    Shalala D.
    N Engl J Med; 2000 Sep 14; 343(11):808-10. PubMed ID: 10984573
    [No Abstract] [Full Text] [Related]

  • 5. Research involving children: regulations, review boards and reform.
    Gandhi R.
    J Health Care Law Policy; 2005 Sep 14; 8(2):264-330. PubMed ID: 16471026
    [No Abstract] [Full Text] [Related]

  • 6. Reporting problems in human research and resultant investigations by IRBs.
    Maloney DM.
    Hum Res Rep; 2002 Aug 14; 17(8):6-7. PubMed ID: 12731495
    [No Abstract] [Full Text] [Related]

  • 7. Improving protection for research subjects.
    Steinbrook R.
    N Engl J Med; 2002 May 02; 346(18):1425-30. PubMed ID: 11986426
    [No Abstract] [Full Text] [Related]

  • 8. New federal guidance adds duties for institutional review boards (IRBs).
    Maloney DM.
    Hum Res Rep; 2005 Nov 02; 20(11):1-2. PubMed ID: 16358479
    [No Abstract] [Full Text] [Related]

  • 9. Clinical trials face heightened scrutiny as science and commerce appear to merge.
    Lorman AJ.
    J Biolaw Bus; 2001 Nov 02; 4(4):23-32. PubMed ID: 12751494
    [Abstract] [Full Text] [Related]

  • 10. Institutional review boards and the privacy of human research subjects.
    Maloney DM.
    Hum Res Rep; 2002 Aug 02; 17(8):1-2. PubMed ID: 12731492
    [No Abstract] [Full Text] [Related]

  • 11. Biotech and pharma face more costly clinical trials.
    Brower V.
    Nat Biotechnol; 1998 Aug 02; 16(8):714. PubMed ID: 9702762
    [No Abstract] [Full Text] [Related]

  • 12. The impact of escalating regulatory requirements on the conduct of clinical research.
    Gordon BG, Kessinger A, Mann SL, Prentice ED.
    Cytotherapy; 2003 Aug 02; 5(4):309-13. PubMed ID: 12944237
    [Abstract] [Full Text] [Related]

  • 13. New privacy rule has more tasks for IRBs.
    Maloney DM.
    Hum Res Rep; 2001 Feb 02; 16(2):4. PubMed ID: 12530379
    [No Abstract] [Full Text] [Related]

  • 14. How institutional review boards (IRBs) can handle adverse event reports.
    Maloney DM.
    Hum Res Rep; 2006 Jan 02; 21(1):1-3. PubMed ID: 16789305
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. IRBs, data sharing, and privacy of human subjects.
    Maloney DM.
    Hum Res Rep; 2002 Apr 02; 17(4):3. PubMed ID: 12374179
    [No Abstract] [Full Text] [Related]

  • 18. Research infrastructure and IRB/FDA requirements.
    Cohen J.
    Med Health R I; 2000 Dec 02; 83(12):382-5. PubMed ID: 11190124
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.